An Overview of Januz Kinase Inhibitors

Online Makale

Online Hizmetlere Toplu Bakış Online Kayıt ve Konaklama Online Bilimsel Program Dernekler İçin... Referanslarımız Telefon ve e-posta Desteği Bildiri özeti nedir? Bildiri özeti nasıl hazırlanır? Bildiri özeti örnekleri Kabul mektubu örnekleri

Rheumatology Quarterly

An Overview of Januz Kinase Inhibitors [Rheumatol Q]

Rheumatol Q. Ahead of Print: QRH-62207

An Overview of Januz Kinase Inhibitors

Dr Fatih Albayrak
Dr. Ersin Arslan Training and Research Hospital Rheumatology Clinic,Gaziantep,Turkey

With a better understanding of the pathogenesis of inflammatory rheumatic diseases, many different treatment pathways entered our lives. In recent years, Januz kinase inhibitors constitute one of these treatment pathways. It has come into clinical use as an effective treatment agent, especially in rheumatoid arthritis and spondyloarthropathy group diseases. In the 21st century, experimental and clinical studies are carried out on Januz kinase inhibitors in many different disease groups apart from rheumatological diseases around the world. In this review, we aimed to briefly talk about the historical development and clinical use of Januz kinases.

Keywords: Januz kinase inhibitor, rheumatological diseases, history

Corresponding Author: Dr Fatih Albayrak, Türkiye

TOOLS